Pfizer 's Hospira plant in McPherson , Kansas has repeatedly breached the US Food and Drug Administration 's good practice standards since 2012 . The FDA ’s latest inspection of the company ’s human sterile drug manufacturing site between July and August 2018 recorded violations in 2017 , including an insufficient investigation into the discovered presence of cardboard in vials . Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting claims of not meeting established specifications with batches of a drug . Other violations include persistent manufacturing errors in certain areas and inadequate training of workers .
Pfizer's Hospira plant in McPherson, Kansas has repeatedly breached the US Food and Drug Administration's good practice standards since 2012. The organisation’s latest inspection of the company’s human sterile drug manufacturing site between July and August followed recorded violations in 2017, including an insufficient investigation into the discovered presence of cardboard in vials. Violations dating from 2012 include failing to stop supposedly sterile drugs from being contaminated and laxity in reporting instances of not meeting established specifications with batches of a drug. Other violations include persistent manufacturing issues in processing areas and inadequate training of staff.